Breathing dust, fumes, and other toxic substances from burn pits, exposed  troops deployed overseas, and those who worked for government contractors abroad and other civilians, to a serious hazards. Some of the chemicals were a very toxic carcinogens and are deadly.

Jon Gelman has been named again to Best Lawyers in America®. This recognition has been bestowed upon him for almost 2 decades. 

Selection to Best Lawyers® is based on an exhaustive and rigorous peer-review survey comprising more than 2.5 million confidential evaluations by the top attorneys in the country. Because no fee or purchase is required, being listed in Best Lawyers is considered a singular honor. The annual, advertisement-free publication has been described in The American Lawyer as “the most respected referral list of attorneys in practice.”
 

A lawsuit was filed alleging that KRB, Inc. (NYSE KRB) endangered the health and safety of American soldiers in Iraq and Afghanistan by exposing them to huge quantities of toxic dust, fumes and other air pollution by burning unsorted was in vast open-air pits without any safety controls

On January 2, 2010, President Barack Obama signed the James Zadroga 9/11 Health and Compensation Act establishing the World Trade Health Program and extends and expands eligibility for compensation under the September 11th Victim Compensation Fund of 2001.

 Jon L. Gelman has received the top rating of "Superb" from Avvo. The rating indicated a perfect score in: experience, industry recognition and professional conduct.

Jon L. Gelman, a Charter Fellow of The College of Workers Compensation Lawyers, attended the annual dinner meeting of the organization in San Antonio, Texas last week. At the meeting several new fellows were inducted into the organization.

Jon L. Gelman's 2012 supplement to the 3 volume hard bound practice series, Workers' Compensation Law 3rd Ed.,  has been published. Order these important supplements now. The supplement provide almost a quarter of a century continuing and unparalleled analysis on workers' compensation law. The volumes and supplements are integrated into the Westlaw(R), part of Thomson Reuters system for "Better Results Faster."

Jon L. Gelman is reviewing potential hip replacement lawsuits involving individuals who were implanted with the DePuy Orthopaedics ASR™ XL Acetabular Hip Replacement System or ASR™ Hip Resurfacing System and experienced pain or other symptoms that led to a second hip replacement surgery.

NIOSH (The National Institute for Occupational Health and Safety) has published a booklet to educate Home Healthcare Workers about preventing latex allergies. Latex products are made from natural rubber, and sensitivity can develop after repeated exposure. Limiting exposure to latex can help prevent allergic reactions for both home healthcare workers and their clients.

Jon L. Gelman has been named to the 2011 edition of New Jersey Super Lawyers. Each year, only 5 percent of the lawyers in the state receive this honor.

Breathing dust, fumes and other and other toxic substances, exposed  troops deployed overseas, and those who worked for government contractors abroad and other civilians, to a serious hazards. 

Tekturna®, a blood pressure drug, has been associated with potentially life-threatening side effects such as stroke, kidney injury, high potassium and low blood pressure.

Attorney General Kamala D. Harris today announced a settlement with the manufacturer of Brazilian Blowout products that will require the company to warn consumers and hair stylists that two of its most popular hair smoothing products emit formaldehyde gas. 

 NHSA bans the nonemergency use of portable electronic devices (other than those designed to support the driving task) for all drivers.....

 The United States has yet to ban asbestos, a known carcinogen, and in 2011 the amount of asbestos that the US imports increased according to US government statistics. 

The U.S. Environmental Protection Agency  issued its 25th annual report on the amount of toxic chemicals released in 2010 to the land, air and water by industrial facilities in New Jersey.

 Many seriously injured workers end up living in nursing homes for convenience and care.

Workers' Compensation claims have been increasing for mental stress claims as technology evolves and more workers are feeling more isolated and estranged from their co-workers by technology.

In December 2011, Tekturna® manufacturer Novartis announced its decision to terminate the clinical ALTITUDE study of the blood pressure drug based on the recommendation of the independent Data Monitoring Committee (DMC) overseeing the clinical trial study. 

 Following a November 2011 warning issued by the European Medicines Agency (EMA), the Food and Drug Administration (FDA) decided to reevaluate the safety of Pradaxa®.